Virtual 2021

Browse: Pre-Congress Content Sunday, 05.09.2021 Monday, 06.09.2021 Tuesday, 07.09.2021 Wednesday, 08.09.2021		View the presentations you missed during Congress! More than 1'200 webcasts and slide presentations, 2'300 e-posters and , 3'000 abstracts from the Virtual Congress 2021 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2021; 58: Suppl. 65, abstract number.

Interstitial lung diseases: from disease mechanisms to novel treatment options

Journal session
Chairs: S. Meiners (Sülfeld, Germany), K. Antoniou (Heraklion, Greece)
Aims: To provide new insights into disease pathogenesis; to highlight the clinical promise of disease biomarkers; to consider current diagnostic approaches; to describe the range of treatment options available or being developed for patients with interstitial lung disease; to set out future directions for research and clinical practice.

Download all media

Introduction R. Craven (London, United Kingdom)
Disease pathology in interstitial lung disease E. Renzoni (London, United Kingdom)
Biomarker discovery, development, and implementation in interstitial lung diseases G. Jenkins (London, United Kingdom)
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities P. Spagnolo (Padova (PD), Italy)
Treatment of interstitial lung diseases: current approaches and future directions K. Johannson (Calgary (AB), Canada)
Discussion and Q&A
Conclusions R. Craven (London, United Kingdom)